NEUROCRINE BIOSCIENCES INC — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+28.3% +$178M
$806M
Cost of Revenue↑+89.2% +$8M
$18M
R&D↑+39.1% +$73M
$258M
SG&A↑+4.9% +$14M
$302M
D&A↑+3.2% +$200K
$6M
Operating Income↑+48.5% +$69M
$211M
EBITDA↑+46.6% +$69M
$217M
Interest Expense
$1M
Other Income/Expense↑+38.3% +$8M
$29M
Pretax Income↑+47.2% +$77M
$239M
Tax Provision↑+44.0% +$26M
$86M
Net Income↑+49.1% +$51M
$154M
Operating Margin↑+3.6pts
26.2%
Net Margin↑+2.7pts
19.1%
Effective Tax Rate↓-0.8pts
35.8%
Deferred Tax Assets↓-9.4% -$4M
$37M
NOL Carryforwards
—
ETR (Continuing Operations)
32.2%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
0.4%
Operating Lease Cost↓-0.6% -$100K
$16M
Revenue YoY Variation↑+6.5pts
28.3%
Income YoY Variation↑+19.1pts
48.5%
Revenue QoQ Variation↑+0.4pts
1.3%
Income QoQ Variation↑+11.0pts
-11.8%